Search Within

Advanced Practice Providers

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (51)
  2. Journal Article (27)
Groups
  1. Molecular Imaging and Therapy Service (78)
  2. Radiology, Department of (77)
  3. Nursing (56)
  4. Survivorship Research (53)
  5. Center for Hematologic Malignancies (48)
  6. Department of Medicine (46)

More Groups

People
  1. Heiko Schoder (31)
  2. Kim Kramer (28)
  3. Neeta Pandit-Taskar (28)
  4. Alison Moskowitz (26)
  5. Andrew Zelenetz (26)
  6. Ariela Noy (26)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (3)
  4. 2022 (6)
  5. 2021 (10)
  6. 2020 (5)

More Years

Publications
  1. Blood (21)
  2. Journal of Clinical Oncology (13)
  3. Neuro-Oncology (10)
  4. Pediatric Blood and Cancer (6)
  5. Hematological Oncology (4)
  6. Journal of Nuclear Medicine (3)

More Publications

Publishers
  1. American Society of Hematology (21)
  2. American Society of Clinical Oncology (13)
  3. Oxford University Press (12)
  4. Wiley Blackwell (6)
  5. Wiley Periodicals, Inc (6)
  6. Elsevier Inc. (4)

More Publishers

Results (78)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A Phase I study of ibrutinib combined with rituximab, ifosfamide, carboplatin, and etoposide in patients with relapsed or primary diffuse large B-cell lymphoma
    Meeting Abstract

    Sauter, C. S.; Matasar, M. J.; Schoder, H.; Drullinsky, P.; Gerecitano, J.; Kumar, A.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schöder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • TARC predicts PET-normalization and event free surival in relapsed/refractory Hodgkin lymphoma patients treated with brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Cho, S.; Fleisher, M.; Woo, K. M.; Zhang, Z. G.; Fox, S.; McCall, S. J.; Schoder, H.; Yahalom, J.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system
    Journal Article

    Zeuren, R.; Biagini, A.; Grewal, R. K.; Randolph, G. W.; Kamani, D.; Sabra, M. M.; Shaha, A. R.; Tuttle, R. M.
    Laryngoscope (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schöder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Phase 1b study of R05137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170)
    Meeting Abstract

    Abou-Alfa, G. K.; Yen, C. J.; Carrasquillo, J. A.; Hsu, C. H.; Gansukh, B.; Ma, J.; Hollywood, E.; Wan, P. J.; Shao, Y. Y.; Lin, Z. Z.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save